MedPath

A clinical research regarding an inhalation therapy of the low concentration carbon monoxide (CO) in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary artery hypertension (sPAH)

Not Applicable
Conditions
COPD and sPAH
Registration Number
JPRN-UMIN000002080
Lead Sponsor
Tohoku University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients exposed to high level of ambient CO whose arterial Hb-CO (aHb-CO) concentration was more than 3.0% 2.Current smoker within 4 weeks 3.Patients with cardiac, hepatic, or hematologic diseases 4.Patients with abnormalities of blood coagulation or fibrinolysis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean pulmonary artery pressure
Secondary Outcome Measures
NameTimeMethod
Dyspnea scale (Hugh-Jones scale), distance in 6 minutes walking test, lung function, lipid peroxide, and peripheral blood IL-10 level
© Copyright 2025. All Rights Reserved by MedPath